Now, the much publicised Viagra Pill for women has been approved by the Food, and Drug Administration. This is the first female sexual dysfunction treatment ever approved by the FDA for sales, here in the United States. This drug, clinically referred to as Fibanserin, is made for women with libido issues such as low libido. The Addyi pill's effects on sexual dysfunction, post-menopause, has not been substantiated. Sprout Pharmaceuticals bases it's clinical findings on the pre-menopause female only.
Cost Of Addyi
The male sexual dysfunction medication market is a 2 billion industry for its manufacturer, Pfizer INC, last year. Addyi will be priced, like Pfizer's Viagra, for about $300 to $400 for a month's supply. The FDA has approved Addyi for women diagnosed with a hypoactive sexual desire disorder. The symptoms of this condition in a female are a low libido that causes stress.
Good Results From Clinical Trials
Since Addyi is such a new drug, there is not a lot of information from patients yet as to how effective the medication is. The clinical trials, overall, show some promising and positive results.
Results of Clinical Trials
Overall, as of 2015, approximately 2 million are on currently seeking treatment for sexual dysfunction issues. The Addyi pill, the manufacturer hopes that their Addyi pill will continue as the treatment for these growing number of women suffering from sexual dysfunction. If you are interested in this medication, seek guidance and assistance from a qualified physician, as you would when being considered for any prescriptive medication.
Site powered by Weebly. Managed by Webspawner by Sibername.com